
SOLD: Licensed EU-GACP cultivation site in Portugal with imminent EU-GMP on post-harvest
Unique opportunity to purchase a European licensed GACP cultivation business with EU-GMP processing pending, and plenty of expansion capability with direct access to Germany and the emerging EU/global cannabis market.
Listing ID:
7821098281
Licence(s) Held:
EU-GACP Licence to Import, Cultivate and Export Cannabis products

Listing Details:
Operating from a ~23,000 ft.², leased, fully built-out indoor cultivation facility in an industrial area
Facility is comprised of 3 flowering rooms, mother room, cloning room, trimming room, 2 drying rooms, 1 safe storage room, 1 packaging room, 3 small testing/experience rooms, nutrients and washing
There is also ~2,100 ft.² of offices, restrooms/changing rooms, lunchroom and computer room
Currently undertaking importation of seeds or plants, propagation, genetics, cultivation, trimming, packaging, labelling, sales, storage and distribution
Total cloning capacity generates over 10.000 clones per cycle
Between 1 to 2 tons of dried cannabis flower per year of current production capacity at the site based on the present operation
Supply agreement in place to sell a minimum 500 Kgs per year of high THC strains for exporting to European markets
Between 2 to 4 tons of dried cannabis flower per year of future production capability
There is an expansion possibility to build other production rooms to double the production capacity in the same industrial area
Anticipate to complete EU-GMP licence by Q3 2022
Open to full purchase, partial purchase opportunities
OUR NEWEST CANNABIS BUSINESS LISTINGS
Explore the newest cannabis business opportunities hitting the market. If you're looking to invest, acquire, or expand your enterprise, these listings are the ideal starting point to grow your footprint in the cannabis industry.
36324927098
Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner

Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential
29345918591
State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub

Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.


